Today, GAP is one of the three largest generic drug companies in Greece and a leader and a specialist in the Cardiovascular and Central Nervous System therapeutic drug categories.
It has developed a large number of generic and inovative formulations whose therapeutic value, quality, efficacy and reliability have placed GAP in the forefront of the Greek pharmaceutical industry since 1949.
At the same time, large foreign firms have trusted GAP for the production and promotion of their products in Greece. In the past, MSD, Beecham and CEFAK have partnered with us, whereas today Vifor Pharma, Ferrer and Henkel trust GAP to promote their products in the Greek market, with significant results.
Our well-organised marketing and sales department, among the most effective in the Greek market, visits 10,000 doctors and 3,500 pharmacies throughout Greece promoting GAP’s products.
Our distribution department not only covers the 3,500 pharmacies but also includes all wholesale drug warehouses and hospitals across the country.